Legacy Bridge’s Biogen BIIB Stock Holding History

Legacy Bridge’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$161K	Sell	880 -30	-3%	-$5.53K	0.06%	153
2025 Q4	$160K	Buy	910 +30	+3%	+$4.9K	0.07%	150
2025 Q3	$123K	Hold	880	–	–	0.05%	163
2025 Q2	$111K	Sell	880 -61	-6%	-$7.6K	0.05%	155
2025 Q1	$129K	Buy	941 +1	+0.1%	+$143	0.07%	150
2024 Q4	$144K	Hold	940	–	–	0.07%	150
2024 Q3	$182K	Hold	940	–	–	0.1%	140
2024 Q2	$218K	Hold	940	–	–	0.13%	126
2024 Q1	$203K	Hold	940	–	–	0.12%	134
2023 Q4	$243K	Hold	940	–	–	0.16%	129
2023 Q3	$242K	Sell	940 -3,900	-81%	-$1.04M	0.17%	130
2023 Q2	$1.38M	Sell	4,840 -1,270	-21%	-$378K	0.92%	39
2023 Q1	$1.7M	Hold	6,110	–	–	1.19%	11
2022 Q4	$1.69M	Buy	6,110 +185	+3%	+$52.3K	1.2%	14
2022 Q3	$1.58M	Hold	5,925	–	–	1.26%	11
2022 Q2	$1.21M	Hold	5,925	–	–	0.89%	31
2022 Q1	$1.25M	Buy	+5,925	New	+$1.29M	0.73%	54

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Legacy Bridge's BIIB Position: Q1 2026 in Review

Legacy Bridge reduced its Biogen (BIIB) stake by 3.3% in Q1 2026, selling an estimated $5.53K and leaving 880 shares worth $161K. The position accounts for 0.06% of the portfolio, ranked #153.

Legacy Bridge first reported a position in BIIB in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.7M in Q1 2023. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Legacy Bridge held 880 shares of Biogen worth $161K as of Q1 2026.
Legacy Bridge sold 30 Biogen shares in Q1 2026, an estimated $5.53K.
Biogen made up 0.06% of Legacy Bridge's portfolio in Q1 2026, its #153 holding.
Legacy Bridge first reported a position in Biogen in Q1 2022 and has held it in 17 quarters since.
Legacy Bridge's Biogen position peaked at $1.7M in Q1 2023.
1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.